Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 5, 2015, Pages 1000-1008.e3

  Siddiqui, Mohammad S ^a   Fuchs, Michael ^a   Idowu, Michael O ^a   Luketic, Velimir A ^a   Boyett, Sherry ^a   Sargeant, Carol ^a   Stravitz, Richard T ^a   Puri, Puneet ^a   Matherly, Scott ^a   Sterling, Richard K ^a   Contos, Melissa ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart disease; Metabolic syndrome; NASH; Obesity; Steatosis

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADIPONECTIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; FATTY ACID; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LEVO GLUCOSE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DYSLIPIDEMIA; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; LIPOGENESIS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; AGED; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; COMPLICATION; FIBROSIS; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ATHEROSCLEROSIS; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; FIBROSIS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84927714113     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.10.008     Document Type: Article

References (25)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Hepatology 2011, 34:274-285.
2. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis andmanagement of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
3. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
4. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. NEngl J Med 2010, 363:1341-1350.
5. Herder C., Karakas M., Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 2011, 90:52-66.
6. Cromwell W.C., Otvos J.D., Keyes M.J., et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management. JClin Lipidol 2007, 1:583-592.
7. Williams P.T., Feldman D.E. Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort. Atherosclerosis 2011, 214:196-202.
8. Lorenzo C., Hanley A.J., Rewers M.J., et al. The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study. Diabetologia 2013, 56:746-757.
9. DeFilippis A.P., Blaha M.J., Martin S.S., et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2013, 227:429-436.
10. Kotronen A., Seppanen-Laakso T., Westerbacka J., et al. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring) 2010, 18:937-944.
11. Kantartzis K., Rittig K., Cegan A., et al. Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions. Diabetes Care 2008, 31:366-368.
12. Adiels M., Taskinen M.R., Packard C., et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006, 49:755-765.
13. Matikainen N., Manttari S., Westerbacka J., et al. Postprandial lipemia associates with liver fat content. JClin Endocrinol Metab 2007, 92:3052-3059.
14. Fabbrini E., Magkos F., Mohammed B.S., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009, 106:15430-15435.
15. Cali A.M., Zern T.L., Taksali S.E., et al. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care 2007, 30:3093-3098.
16. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
17. Younossi Z.M., Stepanova M., Rafiq N., et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011, 53:1874-1882.
18. Kotronen A., Peltonen M., Hakkarainen A., et al. Prediction of alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009, 137:865-872.
19. Folch J., Lees M., Sloane Stanley G.H. Asimple method for the isolation and purification of total lipides from animal tissues. JBiol Chem 1957, 226:497-509.
20. Gibbons G.F., Wiggins D., Brown A.M., et al. Synthesis and function of hepatic very-low-density lipoprotein. Biochem Soc Trans 2004, 32:59-64.
21. Simonen P., Kotronen A., Hallikainen M., et al. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. JHepatol 2011, 54:153-159.
22. Packard C.J. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003, 31:1066-1069.
23. Min H., Kapoor A., Fuchs M., et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metabolism 2012, 15:665-674.
24. Tessari P., Coracina A., Cosma A., et al. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2009, 19:291-302.
25. Schwarz J.M., Linfoot P., Dare D., et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003, 77:43-50.